Discover 1,443 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
Active & Responsive
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
for
Obesity, Overweight and/or Obesity, Overweight
Location: New Port Richey FL, Lecanto FL, Crystal River FL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07595549
Phase3, Recruiting
Active & Responsive
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
for
Breast Cancer, Breast Neoplasm, Breast Cancer Stage IV
Location: Sarasota FL, Nashville TN, Beverly Hills CA
Sponsor: MBQ Pharma
Sex: All
Age: 21+
Code: NCT06075810
Phase1, Recruiting
Active & Responsive
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
for
Triple Negative Breast Cancer, HER2-negative Breast Cancer,
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
for
Leadless Pacemaker, Bradycardia, AV Block,
Location: Sarasota FL, Orlando FL, Charlotte NC, Winston-Salem NC,
Sponsor: Biotronik, Inc.
Sex: All
Age: 18+
Code: NCT07118358
Recruiting
Active & Responsive
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
for
Locally Advanced Pancreatic Cancer
Location: Sarasota FL, Miami FL, Greenville SC, Charlotte NC,
Sponsor: RenovoRx
Sex: All
Age: 18+
Code: NCT03257033
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Secukinumab Open Label Roll-over Extension Protocol
for
Autoimmunity, Inflammation
Location: Zephyrhills FL, Boca Raton FL
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 6 - 70+
Code: NCT04638647
Recruiting
Active & ResponsiveNew
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.